BBLGBone Biologics Corporation

$2M

FY 2012 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$5,231

Net Income

-$715

EPS (Diluted)

$-49.11

Cash Flow

Operating Cash Flow

-$447

Free Cash Flow

-$447

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$0

Total Liabilities

$4,678

Stockholders' Equity

-$4,676

Cash & Equivalents

$0

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$3,000	+100.0%
Operating Income	-$5,231	-$4,520	-15.7%
Net Income	-$715	$0	—

BBLG FY 2012 Earnings — Bone Biologics Corporation Revenue & Financial Results | Market Cap Arena